We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVTY icon
376
Revvity
RVTY
$12.3B
$2.86M 0.05%
42,000
-46,000
-52% -$2.86M
CME icon
377
CME Group
CME
$92.2B
$2.83M 0.05%
22,610
-908
-4% -$109K
CAG icon
378
Conagra Brands
CAG
$7.07B
$2.79M 0.05%
77,954
+3,538
+5% +$137K
CCL icon
379
Carnival Corporation Ltd
CCL
$36.1B
$2.79M 0.05%
42,517
+19,068
+81% +$1.19M
VNDA icon
380
Vanda Pharmaceuticals
VNDA
$312M
$2.77M 0.05%
170,000
-67,000
-28% -$966K
CHRS icon
381
Coherus Oncology
CHRS
$217M
$2.77M 0.05%
193,000
-95,000
-33% -$1.83M
OMC icon
382
Omnicom Group
OMC
$22.7B
$2.77M 0.05%
33,368
-100,040
-75% -$8.34M
SHW icon
383
Sherwin-Williams
SHW
$78.3B
$2.76M 0.05%
23,595
+762
+3% +$85.1K
BSX icon
384
Boston Scientific
BSX
$65.8B
$2.74M 0.05%
98,868
-244,564
-71% -$6.49M
CAH icon
385
Cardinal Health
CAH
$53.4B
$2.73M 0.05%
35,047
+5,299
+18% +$400K
EXC icon
386
Exelon
EXC
$48.6B
$2.71M 0.05%
105,198
+3,474
+3% +$88.4K
BRCD
387
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$2.7M 0.05%
214,418
-3,508
-2% -$44.2K
WFM
388
DELISTED
Whole Foods Market Inc
WFM
$2.7M 0.05%
64,184
+40,000
+165% +$1.46M
WMT icon
389
Walmart Inc
WMT
$871B
$2.7M 0.05%
106,869
+57,825
+118% +$1.47M
CDW icon
390
CDW
CDW
$17.1B
$2.69M 0.05%
43,081
-15,528
-26% -$929K
OVV icon
391
Ovintiv
OVV
$17.5B
$2.69M 0.05%
61,131
+4,229
+7% +$219K
RRC icon
392
Range Resources
RRC
$9.11B
$2.66M 0.05%
114,787
+14,472
+14% +$365K
SBAC icon
393
SBA Communications
SBAC
$18.4B
$2.65M 0.05%
19,664
ENB icon
394
Enbridge
ENB
$124B
$2.62M 0.05%
65,884
+4,557
+7% +$183K
CTSH icon
395
Cognizant
CTSH
$21.5B
$2.61M 0.05%
39,364
+2,569
+7% +$163K
LUV icon
396
Southwest Airlines
LUV
$22.1B
$2.61M 0.05%
42,032
-144,976
-78% -$8.44M
VYX icon
397
NCR Voyix
VYX
$1.06B
$2.61M 0.05%
104,193
-25,337
-20% -$643K
ICE icon
398
Intercontinental Exchange
ICE
$82.4B
$2.58M 0.05%
39,218
+1,726
+5% +$106K
YUM icon
399
Yum! Brands
YUM
$41B
$2.58M 0.05%
34,931
-55,414
-61% -$3.86M
PFG icon
400
Principal Financial Group
PFG
$23.6B
$2.57M 0.05%
40,070
+4,465
+13% +$283K

Similar funds

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.